✦ LIBER ✦

Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity

✍ Scribed by Dante J. Marciani

Book ID: 114384520
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 135 KB
Volume: 8
Category: Article
ISSN: 1359-6446
DOI: 10.1016/s1359-6446(03)02864-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mechanism of action of licensed vaccine

Mechanism of action of licensed vaccine adjuvants

✍ Elaine Tritto; Flaviana Mosca; Ennio De Gregorio 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Immunogenicity, protective efficacy and

Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine

✍ Orli Even-Or; Sarit Samira; Eli Rochlin; Shobana Balasingam; Alex J. Mann; Rob L 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 642 KB

Interferon-α as Antiviral and Antitumor

Interferon-α as Antiviral and Antitumor Vaccine Adjuvants: Mechanisms of Action and Response Signature

✍ Aricò, Eleonora; Belardelli, Filippo 📂 Article 📅 2012 🏛 Mary Ann Liebert 🌐 English ⚖ 233 KB

Mechanisms of vaccine adjuvant activity:

Mechanisms of vaccine adjuvant activity: initiation and regulation of immune responses by vaccine adjuvants

✍ Virgil E.J.C. Schijns 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Predictive markers of safety and immunog

Predictive markers of safety and immunogenicity of adjuvanted vaccines

✍ Mastelic, Beatris; Garçon, Nathalie; Del Giudice, Giuseppe; Golding, Hana; Grube 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 414 KB

Development of Novel Vaccines || Enhanci

Development of Novel Vaccines || Enhancing and Tailoring the Immunogenicity of Vaccines with Novel Adjuvants

✍ von Gabain, Alexander; Klade, Christoph 📂 Article 📅 2012 🏛 Springer Vienna 🌐 German ⚖ 897 KB

“Development of novel vaccines” gives an overview of the tasks in basic research leading to the final product – the vaccine and its applications, belonging to the most complex biologics in the pharmaceutical field. Distinct from most textbooks in the vaccine arena, the current issue focuses on the t